In addition, low levels of tumor-infiltrating CD3+CD56+ NKT-like cells were also positively correlated with advanced clinical features, including tumor size, tumor invasion, distant metastasis and tumor-node-metastasis (TNM) stages (Supplementary Figure S1). This evidence concerns the gene NCAM1 and neoplasm.